Cargando…
Nanocarrier System: State-of-the-Art in Oral Delivery of Astaxanthin
Astaxanthin (3,3′-dihydroxy-4,4′-diketo-β-β carotene), which belongs to the xanthophyll class, has shown potential biological activity in in vitro and in vivo models including as a potent antioxidant, anti-lipid peroxidation and cardiovascular disease prevention agent. It is mainly extracted from an...
Autores principales: | Abdol Wahab, Nur Rafiqah, Meor Mohd Affandi, Meor Mohd Redzuan, Fakurazi, Sharida, Alias, Ekram, Hassan, Haniza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495775/ https://www.ncbi.nlm.nih.gov/pubmed/36139750 http://dx.doi.org/10.3390/antiox11091676 |
Ejemplares similares
-
Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir
por: Hassan, Haniza, et al.
Publicado: (2021) -
Detection of Astaxanthin at Different Regions of the Brain in Rats Treated with Astaxanthin Nanoemulsion
por: Chik, Mazzura Wan, et al.
Publicado: (2022) -
Acyclovir-Loaded Solid Lipid Nanoparticles: Optimization, Characterization and Evaluation of Its Pharmacokinetic Profile
por: Hassan, Haniza, et al.
Publicado: (2020) -
Astaxanthin as a Potent Antioxidant for Promoting Bone Health: An Up-to-Date Review
por: Davan, Iswari, et al.
Publicado: (2023) -
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities
por: Ruman, Umme, et al.
Publicado: (2020)